A new strategy in the war on renal cell cancer: hitting multiple targets with limited collateral damage
- PMID: 16757727
- DOI: 10.1001/jama.295.21.2537
A new strategy in the war on renal cell cancer: hitting multiple targets with limited collateral damage
Comment on
-
Sunitinib in patients with metastatic renal cell carcinoma.JAMA. 2006 Jun 7;295(21):2516-24. doi: 10.1001/jama.295.21.2516. JAMA. 2006. PMID: 16757724 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
